Primary outcome |
The Modified Rankin Scale (mRS) score |
The Modified Rankin Scale (mRS) score |
Change from baseline to 14, 28, 60, 90, and 180 days |
Proportional-odds logistic-regression model |
Baseline, 14, 28, 60, 90, and 180 days |
Secondary outcome |
National Institutes of Health Stroke Scale (NIHSS) score |
National Institutes of Health Stroke Scale (NIHSS) score |
Change from screening period to 14, 28, 60, and 90 days |
Repeated-measures analysis model |
Screening period, 14, 28, 60, and 90 days |
Activity of Daily Living (ADL) Scale score (Barthel index) |
Activity of Daily Living (ADL) Scale score (Barthel index) |
Change from baseline to 90 and 180 days |
Repeated-measures analysis model |
Baseline, 90 and 180 days |
Prothrombin time (PT) |
Prothrombin time (PT) |
Change from baseline to 14, 28, 60, and 90 days |
Repeated-measures analysis model |
Baseline, 14, 28, 60, and 90 days |
Activated partial thromboplastin time (APTT) |
Activated partial thromboplastin time (APTT) |
Change from baseline to 14, 28, 60, and 90 days |
Repeated-measures analysis model |
Baseline, 14, 28, 60, and 90 days |
Serum fibrinogen (FIB) concentration |
Serum fibrinogen (FIB) concentration |
Change from baseline to 14, 28, 60, and 90 days |
Repeated-measures analysis model |
Baseline, 14, 28, 60, and 90 days |
Serum hypersensitive C-reactive protein (hs-CRP) |
Serum hypersensitive C-reactive protein (hs-CRP) |
Change from baseline to 90 days |
Repeated-measures analysis model |
Baseline, 90 days |